Cargando…
Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model
The stromal derived factor-1 (SDF-1)/CXCR4 axis is associated with tumor aggressiveness and metastasis in prostate cancer. The present study aimed to explore the potential therapeutic effects of a CXCR4 antagonist in prostate cancer. The effect of SDF-1 and a CXCR4-specific antagonist, AMD3100, on h...
Autores principales: | CHO, KANG SU, YOON, SO JUNG, LEE, JOO YONG, CHO, NAM HOON, CHOI, YOUNG DEUK, SONG, YUN SEOB, HONG, SUNG JOON |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3796427/ https://www.ncbi.nlm.nih.gov/pubmed/24137439 http://dx.doi.org/10.3892/ol.2013.1515 |
Ejemplares similares
-
Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer
por: Lee, Joo Yong, et al.
Publicado: (2014) -
Fluorescent CXCR4 chemokine receptor antagonists: metal activated binding
por: Khan, Abid, et al.
Publicado: (2007) -
Exploratory Studies on Development of the Chemokine Receptor CXCR4 Antagonists Toward Downsizing
por: Tamamura, Hirokazu, et al.
Publicado: (2008) -
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t
por: Ward, Richard J., et al.
Publicado: (2020) -
Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain
por: Piotrowska, Anna, et al.
Publicado: (2018)